Skip to main content
    T

    Tevogen Bio Holdings Inc. (TVGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.22
    +0.22 (+3.67%)

    Market Cap: $406.59M

    Last updated: Nov 17, 2026 at 3:04 AM ET

    Tevogen Bio Holdings Inc. (TVGN) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Tevogen Bio Holdings (TVGN) to earn -$10.00 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$13.00.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Dec 31, 2026
    -$10.00
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$13.00
    EPS consensus
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$10.00-$10.00 to -$10.001
    Dec 31, 2027-$13.00-$13.00 to -$13.001

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202701

    EPS Trend

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$10.00-$11.00-$11.00-$11.00-$11.00N/A
    Fiscal year ending Dec 31, 2027-$13.00$55.50$55.50$55.50$55.50N/A

    Frequently Asked Questions About TVGN

    What is the TVGN stock forecast?

    Consensus analyst estimates put Tevogen Bio Holdings's EPS at -$10.00 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from TVGN next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$10.00, with estimates from -$10.00 to -$10.00 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$13.00, with estimates from -$13.00 to -$13.00 from 1 analyst.

    How many analysts cover TVGN?

    1 analyst estimates EPS for Tevogen Bio Holdings for the fiscal year ending Dec 31, 2026.